HBL HADASIT BIO HOLDINGS

hbl-hadasit-bio-holdings-logo

Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) and recently on the OTC (OTCBB : HADSY ) in order to allow public participation in the highly promising field of biotechnology. It serves as a precedent in biotech financing - for the first time, public investment is allowed to participate in a holding entity including companies based on IP generated by Israelโ€™s foremost medical research center โ€“ Hadassah University Hospital ("HU"). ... In addition to the public holdings (54%) โ€“ including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il) (36%) and Consensus Business Group (http://www.consensusbusiness.com) (10%). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 6 biotech companies - all based on inventions developed and owned by HU. HBL is a publicly traded subsidiary of Hadasit Ltd. โ€“ the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. Hadasit was established for the purpose of promoting and commercializing the intellectual property (IP) and R&D capabilities generated by Hadassah, aimed at finding solutions to problems faced by modern medicine.

#SimilarOrganizations #People #Financial #More

HBL HADASIT BIO HOLDINGS

Social Links:

Industry:
Biopharma Biotechnology Life Science

Founded:
2005-01-01

Status:
Active

Email Addresses:
[email protected]

Total Funding:
2 M USD

Technology used in webpage:
SPF Google Analytics Microsoft Exchange Online Office 365 Mail Google Maps Microsoft Azure DNS ASP.NET IIS Google Analytics Classic IIS 8


Similar Organizations

emmaus-medical-logo

Emmaus Medical

Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.

Current Employees Featured

rafi-hofstein_image

Rafi Hofstein
Rafi Hofstein President & CEO @ HBL Hadasit Bio Holdings
President & CEO
1999-01-01

liat-hadad-simhayoff_image

Liat Hadad Simhayoff
Liat Hadad Simhayoff CFO @ HBL Hadasit Bio Holdings
CFO
2012-06-01

Founder


rafi-hofstein_image

Rafi Hofstein

Stock Details


Company's stock symbol is TLV:HDST

Investments List

Date Company Article Money raised
2021-06-16 KAHR medical HBL Hadasit Bio Holdings investment in Venture Round - KAHR medical 46.5 M USD
2020-02-25 KAHR medical HBL Hadasit Bio Holdings investment in Venture Round - KAHR medical 18 M USD
2018-04-23 Enlivex Therapeutics HBL Hadasit Bio Holdings investment in Venture Round - Enlivex Therapeutics 10 M USD
2017-09-19 Enlivex Therapeutics HBL Hadasit Bio Holdings investment in Series B - Enlivex Therapeutics 8 M USD
2013-09-09 KAHR medical HBL Hadasit Bio Holdings investment in Venture Round - KAHR medical 2.35 M USD
2011-04-14 KAHR medical HBL Hadasit Bio Holdings investment in Venture Round - KAHR medical 3 M USD
2010-04-23 ProtAb HBL Hadasit Bio Holdings investment in Series A - ProtAb 4 M USD
2009-12-01 KAHR medical HBL Hadasit Bio Holdings investment in Venture Round - KAHR medical 1.5 M USD
2009-01-28 KAHR medical HBL Hadasit Bio Holdings investment in Venture Round - KAHR medical 500 K USD

More informations about "HBL Hadasit Bio Holdings" on Search Engine